Additional file 1 of PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Fields of Study & Subjects
Protein Degradation and Inhibitors
Cell death mechanisms and regulation
Melanoma and MAPK Pathways
Publication details
- Journal / source
- Figshare
- Publication date
- 1 January 2026